Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 100

Results For "CAS"

1564 News Found

Biocon - Generics & research grow; biosimilar stagnates - ICICI Securities
News | May 26, 2022

Biocon - Generics & research grow; biosimilar stagnates - ICICI Securities

ICICI Direct expects revenue CAGR of 35.6% over FY22-FY24E mainly due to the consolidation of Viatris business and they expect EBITDA margin expansion of 230bps and earnings CAGR of 64.8% over FY22-FY24E


Borrena approval strengthens Pfizer position in China NSCLC market: GlobalData
News | May 25, 2022

Borrena approval strengthens Pfizer position in China NSCLC market: GlobalData

According to GlobalData’s ‘Pharmaceutical Intelligence Center’, the number of diagnosed prevalent cases of ALK-mutant NSCLC in China is estimated to grow at a CAGR of 5.3% from 22,725 in 2021 to 31,902 in 2029


Thyrocare launches its Regional Processing Lab in Nagpur on World Thyroid Day
Diagnostic Center | May 25, 2022

Thyrocare launches its Regional Processing Lab in Nagpur on World Thyroid Day

The new advanced regional processing lab will serve Nagpur city and the Vidarbha region


Sputnik V demonstrates strong protection against Omicron variant
Biotech | May 25, 2022

Sputnik V demonstrates strong protection against Omicron variant

The study was conducted in equal laboratory conditions in the Spallanzani Institute in Italy on comparable sera samples from individuals vaccinated with Sputnik V and Pfizer with a similar level of IgG antibodies and virus-neutralizing activity (VNA) against Wuhan variant.


Indica Labs achieves CE-IVD certification for AI-based prostate cancer detection and Gleason grading tool
Digitisation | May 24, 2022

Indica Labs achieves CE-IVD certification for AI-based prostate cancer detection and Gleason grading tool

The HALO Prostate AI algorithm deployed in HALO AP from Indica Labs


Alembic Pharmaceuticals receives USFDA final approval for Pirfenidone tablets
Drug Approval | May 24, 2022

Alembic Pharmaceuticals receives USFDA final approval for Pirfenidone tablets

The tablets have an estimated market size of US $ 548 million for twelve months ending December 2021 according to IQVIA


Apollo Hospitals Navi Mumbai doctors perform critical procedure to save 14-month-old baby girl
Hospitals | May 24, 2022

Apollo Hospitals Navi Mumbai doctors perform critical procedure to save 14-month-old baby girl

Successfully removed peanut from the child’s left lung through bronchoscopy


My aim is to help the pharmaceutical industry develop a winning strategy: Dr Rupali Paranjape
interviews | May 23, 2022

My aim is to help the pharmaceutical industry develop a winning strategy: Dr Rupali Paranjape

Dr Rupali Paranjape, an experienced regulatory and compliance consultant and author of Blue Ocean of Compliance shares insights on her book in an interview with Thomas C Thottathil, Editor, www.indianpharmapost.com


Launch of joint research to collect a year’s worth of lifestyle data through wearable tracking device
Healthcare | May 23, 2022

Launch of joint research to collect a year’s worth of lifestyle data through wearable tracking device

Objective tracking data combined with cohort data to drive medicine of the future


Vaxzevria approved in the EU as third dose booster against Covid-19
Drug Approval | May 23, 2022

Vaxzevria approved in the EU as third dose booster against Covid-19

Approval follows CHMP recommendation for use in patients previously vaccinated with Vaxzevria or an EU-approved mRNA Covid-19 vaccine